|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.00543789
|
|
|
VRNI
|
[NCBI]
|
0.00159824
|
|
|
C4A
|
[NCBI]
|
0.00141962
|
|
|
C4B
|
[NCBI]
|
0.00133326
|
|
|
MBL2
|
[NCBI]
|
0.000459478
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
0.00032055
|
|
|
CF
|
[NCBI]
|
0.000298252
|
|
|
CFB
|
[NCBI]
|
0.00028199
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000207409
|
|
|
C4BPA
|
[NCBI]
|
0.00018009
|
|
|
HAE
|
[NCBI]
|
0.000175772
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
0.000123821
|
|
|
CR1
|
[NCBI]
|
0.000100858
|
|
|
FBD
|
[NCBI]
|
9.23294e-05
|
|
|
FDD
|
[NCBI]
|
9.23294e-05
|
|
|
CHBL
|
[NCBI]
|
8.05051e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
7.28613e-05
|
|
|
aHUS
|
[NCBI]
|
7.1628e-05
|
|
|
TNXB
|
[NCBI]
|
7.0605e-05
|
|
|
HAE III
|
[NCBI]
|
6.72029e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
6.00982e-05
|
|
|
C3
|
[NCBI]
|
5.43693e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
5.06366e-05
|
|
|
CFD
|
[NCBI]
|
4.98686e-05
|
|
|
KTCN1
|
[NCBI]
|
4.64787e-05
|
|
|
AGS1
|
[NCBI]
|
4.64787e-05
|
|
|
CFH
|
[NCBI]
|
4.26015e-05
|
|
|
DKC
|
[NCBI]
|
3.63373e-05
|
|
|
EKV
|
[NCBI]
|
3.5237e-05
|
|
|
DOM3Z
|
[NCBI]
|
3.1958e-05
|
|
|
NRCLP1
|
[NCBI]
|
2.81987e-05
|
|
|
MASP2
|
[NCBI]
|
2.59937e-05
|
|
|
SKIV2L
|
[NCBI]
|
2.59937e-05
|
|
|
C4BPB
|
[NCBI]
|
2.49188e-05
|
|
|
ACAT2
|
[NCBI]
|
2.40256e-05
|
|
|
MASP1
|
[NCBI]
|
2.40256e-05
|
|
|
AIF1
|
[NCBI]
|
2.40256e-05
|
|
|
AD
|
[NCBI]
|
2.24786e-05
|
|
|
CR2
|
[NCBI]
|
2.14679e-05
|
|
|
TREX1
|
[NCBI]
|
2.14679e-05
|
|
|
C5R1
|
[NCBI]
|
2.05405e-05
|
|
|
MCP
|
[NCBI]
|
2.00554e-05
|
|
|
HLA-G
|
[NCBI]
|
1.76662e-05
|
|
|
PI
|
[NCBI]
|
1.48686e-05
|
|
|
PROS1
|
[NCBI]
|
1.43399e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.38492e-05
|
|
|
CD
|
[NCBI]
|
1.22804e-05
|
|
|
A2M
|
[NCBI]
|
1.20101e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.12612e-05
|
|
|
BTK
|
[NCBI]
|
1.06734e-05
|
|
|
HLA-A
|
[NCBI]
|
1.01497e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
9.6321e-06
|
|
|
PRL
|
[NCBI]
|
9.4995e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
9.37684e-06
|
|
|
ALB
|
[NCBI]
|
8.40829e-06
|
|
|
AR
|
[NCBI]
|
5.65118e-06
|
|
|
PLG
|
[NCBI]
|
5.17712e-06
|
|
|
MG
|
[NCBI]
|
3.17132e-06
|
|
|
EPO
|
[NCBI]
|
2.45868e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.15887e-06
|
|
|
HP
|
[NCBI]
|
2.13725e-06
|
|
|
TNF
|
[NCBI]
|
1.25822e-06
|
|
|
AFP
|
[NCBI]
|
1.12214e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.08106e-06
|
|
|
RP
|
[NCBI]
|
4.22099e-07
|
|
|
GFAP
|
[NCBI]
|
9.28604e-08
|
|
|
ADA
|
[NCBI]
|
6.78682e-08
|
|
|
G6PD
|
[NCBI]
|
6.48444e-08
|
|
|
TG
|
[NCBI]
|
2.98791e-08
|
|
|
FMF
|
[NCBI]
|
9.26928e-09
|
|
|
RA
|
[NCBI]
|
8.64685e-09
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
6.80029e-09
|
|